- Home
- HSAI vs ARWR Comparison
HSAI vs ARWR Comparison
Compare HSAI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSAI
- ARWR
- Stock Information
- Founded
- HSAI 2014
- ARWR 2003
- Country
- HSAI China
- ARWR United States
- Employees
- HSAI N/A
- ARWR N/A
- Industry
- HSAI
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- HSAI
- ARWR Health Care
- Exchange
- HSAI Nasdaq
- ARWR Nasdaq
- Market Cap
- HSAI 2.8B
- ARWR 2.5B
- IPO Year
- HSAI 2023
- ARWR 1993
- Fundamental
- Price
- HSAI $26.49
- ARWR $29.08
- Analyst Decision
- HSAI Strong Buy
- ARWR Strong Buy
- Analyst Count
- HSAI 3
- ARWR 9
- Target Price
- HSAI $30.10
- ARWR $47.75
- AVG Volume (30 Days)
- HSAI 3.2M
- ARWR 3.1M
- Earning Date
- HSAI 08-14-2025
- ARWR 08-07-2025
- Dividend Yield
- HSAI N/A
- ARWR N/A
- EPS Growth
- HSAI N/A
- ARWR N/A
- EPS
- HSAI 0.11
- ARWR N/A
- Revenue
- HSAI $347,701,639.00
- ARWR $572,976,000.00
- Revenue This Year
- HSAI $62.58
- ARWR $22,306.37
- Revenue Next Year
- HSAI $44.42
- ARWR N/A
- P/E Ratio
- HSAI $245.93
- ARWR N/A
- Revenue Growth
- HSAI 36.51
- ARWR 2816.20
- 52 Week Low
- HSAI $3.56
- ARWR $9.57
- 52 Week High
- HSAI $27.94
- ARWR $29.34
- Technical
- Relative Strength Index (RSI)
- HSAI 59.89
- ARWR 83.89
- Support Level
- HSAI $24.60
- ARWR $21.61
- Resistance Level
- HSAI $26.82
- ARWR $29.34
- Average True Range (ATR)
- HSAI 1.85
- ARWR 1.30
- MACD
- HSAI 0.06
- ARWR 0.84
- Stochastic Oscillator
- HSAI 71.79
- ARWR 97.33
About HSAI Hesai Group each ADS represents one Class B ordinary share
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.